Phase II Study of S-1 in Combination With Radiotherapy in Esophageal Squamous Cell Carcinoma
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 04 Feb 2017
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Oesophageal cancer
- Focus Adverse reactions; Therapeutic Use
- 06 Jan 2016 Planned End Date changed from 1 Mar 2018 to 1 Oct 2018 as reported by ClinicalTrials.gov record.
- 06 Jan 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 19 Apr 2013 New trial record